Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal

eqs_en 
0 0 24.03.22
DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal
 

DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Forecast
Eckert & Ziegler to Increase Dividend Proposal

24-March-2022 / 19:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Berlin, March 24, 2022 - Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) closed fiscal year 2021 with sales of 180.4 million EUR (previous year: 176.1 million EUR) and net income of 34.5 EUR (previous year: 22.9 million EUR). Earnings per share amounted to EUR 1.67 (previous year: EUR 1.11). Based on these figures, the Executive Board and Supervisory Board today resolved to propose to the Annual General Meeting the payment of a dividend of EUR 0.50 (previous year: EUR 0.45) per dividend-bearing share.

For the current fiscal year 2022, the Executive Board expects an increase in sales to around EUR 200 million and a net income of around EUR 38 million. The forecast is based on a weighted average exchange rate of USD 1.20 per EUR and is subject to the assumption that no major disruptions continue to result from the developments in Ukraine.

The detailed financial statements for 2021 will be published on March 30, 2022.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com

24-March-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1311583

 
End of Announcement DGAP News Service

1311583  24-March-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1311583&application_name=news&site_id=sharewise

Eckert & Ziegler Strahlen- und Medizintechnik AG Stock

€46.02
0.260%
Eckert & Ziegler Strahlen- und Medizintechnik AG gained 0.260% compared to yesterday.
Eckert & Ziegler Strahlen- und Medizintechnik AG is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
Based on the current price of 46.02 € the target price of 95 € shows a potential of 106.43% for Eckert & Ziegler Strahlen- und Medizintechnik AG which would more than double the current price.
Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!